241 related articles for article (PubMed ID: 33677655)
1. Pelvic exenteration for colorectal and non-colorectal cancer: a comparison of perioperative and oncological outcome.
Bogner A; Fritzmann J; Müssle B; Huber J; Dobroschke J; Bork U; Wolk S; Distler M; Weitz J; Welsch T; Kahlert C
Int J Colorectal Dis; 2021 Aug; 36(8):1701-1710. PubMed ID: 33677655
[TBL] [Abstract][Full Text] [Related]
2. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
[No Abstract] [Full Text] [Related]
3. Retrospective review of pelvic malignancies undergoing total pelvic exenteration.
Kuhrt MP; Chokshi RJ; Arrese D; Martin EW
World J Surg Oncol; 2012 Jun; 10():110. PubMed ID: 22703863
[TBL] [Abstract][Full Text] [Related]
4. Systematic review of outcomes following pelvic exenteration for the treatment of primary and recurrent locally advanced rectal cancer.
Platt E; Dovell G; Smolarek S
Tech Coloproctol; 2018 Nov; 22(11):835-845. PubMed ID: 30506497
[TBL] [Abstract][Full Text] [Related]
5. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies.
Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD; Austin KK
Dis Colon Rectum; 2014 Oct; 57(10):1153-61. PubMed ID: 25203370
[TBL] [Abstract][Full Text] [Related]
6. Total pelvic exenteration for primary and recurrent malignancies.
Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
[TBL] [Abstract][Full Text] [Related]
7. Clinical and oncological outcomes of pelvic exenteration surgery for anal squamous cell carcinoma.
Quyn AJ; Murthy S; Gould L; Said H; Tiernan J; Sagar P; Antoniou A; Jenkins I; Burns EM
Colorectal Dis; 2023 Nov; 25(11):2131-2138. PubMed ID: 37753947
[TBL] [Abstract][Full Text] [Related]
8. Pelvic exenteration for recurrent squamous cell carcinoma of the pelvic organs arising from the cloaca--a single institution's experience over 16 years.
Tan KK; Pal S; Lee PJ; Rodwell L; Solomon MJ
Colorectal Dis; 2013; 15(10):1227-31. PubMed ID: 23714581
[TBL] [Abstract][Full Text] [Related]
9. Curative pelvic exenteration: initial experience and clinical outcome.
Ali Uraiqat A; Al Nsour D; Mestareehy KM; Allababdeh MS; Naffa MTF; Alrabee MM; Al-Hammouri F
Pan Afr Med J; 2023; 44():170. PubMed ID: 37455871
[TBL] [Abstract][Full Text] [Related]
10. Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer.
Bhangu A; Ali SM; Brown G; Nicholls RJ; Tekkis P
Ann Surg; 2014 Feb; 259(2):315-22. PubMed ID: 23478530
[TBL] [Abstract][Full Text] [Related]
11. Survival and morbidity outcomes after pelvic exenteration for pelvic sarcoma: an institutional series.
Lee PJ; Meshkat B; Sasidharan P; Zahid A; Coker DJ; Solomon MJ
ANZ J Surg; 2022 May; 92(5):1038-1043. PubMed ID: 34661958
[TBL] [Abstract][Full Text] [Related]
12. Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer.
Yamada K; Ishizawa T; Niwa K; Chuman Y; Aikou T
Dis Colon Rectum; 2002 Aug; 45(8):1078-84. PubMed ID: 12195193
[TBL] [Abstract][Full Text] [Related]
13. Pelvic Exenteration for Anal and Urogenital Squamous Cell Carcinoma: Experience and Outcomes from an Exenteration Unit Over 12 Years.
Smith N; Waters PS; Peacock O; Kong JC; McCormick J; Warrier SK; McNally O; Lynch AC; Heriot AG
Ann Surg Oncol; 2020 Jul; 27(7):2450-2456. PubMed ID: 31993856
[TBL] [Abstract][Full Text] [Related]
14. [Urinary complications of pelvic exenterations for rectal cancer with urinary invasion].
Gas J; Beauval JB; Chalret du Rieu M; Bou Nasr E; Philis A; Kirzin S; Thoulouzan M; Soulié M; Ghouti L
Prog Urol; 2015 May; 25(6):348-54. PubMed ID: 25804429
[TBL] [Abstract][Full Text] [Related]
15. Pelvic exenteration and composite sacral resection in the surgical treatment of locally recurrent rectal cancer.
Gawad W; Khafagy M; Gamil M; Fakhr I; Negm M; Mokhtar N; Lotayef M; Mansour O
J Egypt Natl Canc Inst; 2014 Sep; 26(3):167-73. PubMed ID: 25150132
[TBL] [Abstract][Full Text] [Related]
16. Complications and 5-year survival after radical resections which include urological organs for locally advanced and recurrent pelvic malignancies: analysis of 646 consecutive cases.
Peacock O; Waters PS; Kong JC; Warrier SK; Wakeman C; Eglinton T; Murphy DG; Heriot AG; Frizelle FA; McCormick JJ
Tech Coloproctol; 2020 Feb; 24(2):181-190. PubMed ID: 31907722
[TBL] [Abstract][Full Text] [Related]
17. Outcome of total pelvic exenteration for locally recurrent rectal cancer.
Ike H; Shimada H; Ohki S; Yamaguchi S; Ichikawa Y; Fujii S
Hepatogastroenterology; 2003; 50(51):700-3. PubMed ID: 12828064
[TBL] [Abstract][Full Text] [Related]
18. Is an uncomplicated postoperative recovery following total pelvic exenteration a more important prognostic factor than achieving R0 in the first 2 years?
Ralston C; Hainsworth A; de Naurois J; Schizas A; George M
Colorectal Dis; 2024 Jan; 26(1):73-80. PubMed ID: 38071402
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer.
PelvEx Collaborative
Br J Surg; 2018 May; 105(6):650-657. PubMed ID: 29529336
[TBL] [Abstract][Full Text] [Related]
20. Role of pelvic exenteration in the management of locally advanced primary and recurrent rectal cancer.
Xin KY; Ng DW; Tan GH; Teo MC
J Gastrointest Cancer; 2014 Sep; 45(3):291-7. PubMed ID: 24563189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]